Categories: Technology

Melexis: update on the share buy-back program

 | Source: Melexis N.V.

Press release – Regulated Information

Ieper, Belgium – 15 December 2025, 17.45 hrs CET

Melexis reports the purchase of 33,000 Melexis shares on Euronext Brussels in the period from 8 to 12 December 2025, related to the share buy-back program announced on 10 December 2024 which ended on 10 December 2025, and to the share buy-back program announced on 10 December 2025 which started on 11 December 2025.

Trade date Total shares purchased Average price (€) Min price (€) Max price (€) Buyback amount (€)
8/12/2025 9,000 59.30 59.00 60.70 533,728
9/12/2025 8,000 59.00 58.55 59.30 472,011
10/12/2025 8,000 59.03 58.55 60.45 472,214
11/12/2025 4,000 58.36 57.90 58.80 233,420
12/12/2025 4,000 57.89 57.45 58.65 231,568
TOTAL 33,000 58.88 57.45 60.70 1,942,940

Under the share buy-back program announced on 10 December 2025 for up to 850,000 shares, Melexis purchased 8,000 treasury shares. 

Including 831,491 shares purchased under the share buy-back program announced on 10 December 2024 which ended on 10 December 2025, Melexis now holds 839,431 treasury shares.

GlobeNews Wire

Recent Posts

BlueSG Receives Frost & Sullivan’s 2025 Asia-Pacific Customer Value Leadership Recognition for Excellence in Car-sharing Industry

Frost & Sullivan applauds BlueSG's customer-centric approach, digital transformation, and operational agility in redefining urban…

1 hour ago

Healthcare Holding Schweiz Acquires Stake in Medddbase International

Healthcare Holding Schweiz AG, a leading service provider and distributor of medical technology in Switzerland, expands…

1 hour ago

Bybit’s 2026 Crypto Outlook Challenges the Four-Year Crypto Cycle

DUBAI, UAE, Jan. 6, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume,…

1 hour ago

KuCoin Releases Australia Market Report: Over Half of Australian Crypto Funding Comes from Bank Transfers

The findings highlight growing demand for regulated exchanges that support seamless fiat on- and off-rampsSYDNEY,…

1 hour ago

Day One Completes Acquisition of Mersana Therapeutics

Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting…

8 hours ago

Medical AI Expert Wido Menhardt Joins FemPulse Scientific Advisory Board

January 06, 2026 09:00 ET  | Source: FemPulse SAN FRANCISCO, Jan. 06, 2026 (GLOBE NEWSWIRE)…

8 hours ago